ARCHIVES

In Breif: FDA Issues Uterine Cancer-Tamoxifin Warning; Fisher Declined Invitation To Speak At AACR

This article is from The Cancer Letter archive.

Vol. 20 No. 15 | April 15, 1994

Download PDF Visit The Full Archive

Related Articles

In Brief CCOP Prospects Submit 130 Letters Of Intent; DeVita recovering On Schedule from Surgery

September 26, 1986

UC Davis Is U.S. Site For Trial Of Exemestane For Breast Ca.

September 24, 2004

As NCI Sets Deadline For B-06 Reanalysis, Fisher Lawyer Says Demand Is Illegal

February 3, 1995

NCI Programs: Researchers Take “Director’s Challenge” to Develop Molecular Profiles of Tumors

December 10, 1999

DCT Advisors Okay Two New RFA Concepts In Clinical Research, Biodiversity Groups

November 8, 1991

Search Committee Finishes Job, Submits Choices To Califano

April 15, 1977